Brooks Laboratories Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|
| Revenue | 20.99 | 18 | 18.38 |
| Operating Expense | 19.28 | 17.65 | 17.34 |
| Net Profit | 0.96 | -0.21 | 0.30 |
| Net Profit Margin | 4.57 | -1.17 | 1.63 |
| Earning Per Share | 0.36 | -0.08 | 0.10 |
| EBIDTA | 1.71 | 0.35 | 1.03 |
| Effective Tax Rate | TBA | TBA | TBA |
| Particulars | Sep 2024 |
|---|---|
| Revenue | 20.99 |
| Operating Expense | 19.28 |
| Net Profit | 0.96 |
| Net Profit Margin | 4.57 |
| Earning Per Share | 0.36 |
| EBIDTA | 1.71 |
| Effective Tax Rate | TBA |
Invest in Brooks Laboratories Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 79.49 | 55.54 | 76.97 |
| Operating Expenses Annual | 76.27 | 61.35 | 75.09 |
| Operating Profit Annual | 4.17 | -5.70 | 2.82 |
| Interest Annual | 0.84 | 0.77 | 0.67 |
| Depreciation | 1.77 | 1.72 | 1.49 |
| Net Profit Annual | 1.53 | -8.18 | 0.67 |
| Tax Annual | 0.03 | TBA | TBA |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 79.49 |
| Operating Expenses Annual | 76.27 |
| Operating Profit Annual | 4.17 |
| Interest Annual | 0.84 |
| Depreciation | 1.77 |
| Net Profit Annual | 1.53 |
| Tax Annual | 0.03 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.02 | 0.08 | 0.06 |
| Cash Flow from Operations | -9.68 | 0.55 | 3.12 |
| Cash Flow from Investing | 0.18 | -0.40 | 1.12 |
| Cash Flow from Financing | 9.60 | -0.21 | -4.23 |
| Cash Flow at the End | 0.13 | 0.02 | 0.08 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 0.02 |
| Cash Flow from Operations | -9.68 |
| Cash Flow from Investing | 0.18 |
| Cash Flow from Financing | 9.60 |
| Cash Flow at the End | 0.13 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 5.25 | -10.26 | 3.33 |
| PBIT Margin (%) | 3.02 | -13.36 | 1.39 |
| PBT Margin (%) | -0.58 | 3.96 | -0.70 |
| Net PROFIT Margin (%) | 1.92 | -14.73 | 0.87 |
| Return On Networth / Equity (%) | 1.90 | TBA | 0.52 |
| Return On Networth /Employed (%) | 2.72 | TBA | 1.23 |
| Return On Assets (%) | 2.16 | -11.78 | 0.91 |
| Total Debt / Equity (X) | 0.10 | 0.10 | 0.11 |
| Asset Turnover Ratio (%) | 1.12 | 0.80 | 1.04 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 5.25 |
| PBIT Margin (%) | 3.02 |
| PBT Margin (%) | -0.58 |
| Net PROFIT Margin (%) | 1.92 |
| Return On Networth / Equity (%) | 1.90 |
| Return On Networth /Employed (%) | 2.72 |
| Return On Assets (%) | 2.16 |
| Total Debt / Equity (X) | 0.10 |
| Asset Turnover Ratio (%) | 1.12 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 13.67 | 15.01 | 15.14 |
| Total Current Assets Annual | 31.05 | 27.61 | 37.04 |
| Non Current Assets Annual | 63.34 | 64.82 | 66.42 |
| Total Shareholders Funds Annual | 69.53 | 56.78 | 65.00 |
| Total Assets Annual | 94.39 | 92.42 | 103.45 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 13.67 |
| Total Current Assets Annual | 31.05 |
| Non Current Assets Annual | 63.34 |
| Total Shareholders Funds Annual | 69.53 |
| Total Assets Annual | 94.39 |
EPS (INR)
Expected
0.00
Reported
-1.51
Surprise
0.00%
Jun 2024
EPS beaten by 0.00%
Mar 2024
EPS beaten by 0.00%
Dec 2023
EPS beaten by 0.00%
